Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03797898 · ClinicalTrials.gov registry record · NA

Well-Child Care Clinical Practice Redesign: A Parent Coach-Led Model of Care

A NA study of Health Promotion and Preventive Health Services, sponsored by Seattle Children's Hospital.

Completed
Registry status
NA
Development phase
937
Enrollment target
2
Study locations

NCT03797898: Completed NA study of Health Promotion and Preventive Health Services, sponsored by Seattle Children's Hospital.

NCT03797898 is a NA study of Health Promotion and Preventive Health Services that has completed, run by Seattle Children's Hospital. The registered enrollment target is 937 participants, below the 8,885-participant average among 10 other Health Promotion trials with a reported enrollment target (89% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03797898, a NA study of Health Promotion and Preventive Health Services, has completed, sponsored by Seattle Children's Hospital.

COMPLETED
Registry status
NA
Development phase
937 participants
Enrollment target
2
Study locations

Study Summary

Parent-focused Redesign for Encounters, Newborns to Toddlers (PARENT) is a team-based approach to care using a health educator ("Parent Coach") to provide the bulk of WCC services, address specific needs faced by families in low-income communities, and decrease reliance on the clinician as the primary provider of WCC services. The Parent Coach provides anticipatory guidance, psychosocial and social needs screening/referral, and developmental and behavioral surveillance, screening, and guidance at each WCC visit, and is supported by parent-focused pre-visit screening and visit prioritization, a brief, problem-focused clinician encounter for a physical exam and any concerns that require a clinician's attention, and an automated text message parent reminder and education service for periodic, age-specific messages to reinforce key health-related information recommended by Bright Futures national guidelines. The investigators will conduct a cluster RCT of PARENT to determine its effects on quality, utilization, and clinician efficiency, and its cost/cost-offset.

Primary Outcome

Using anticipatory guidance items adapted from the Promoting Healthy Development Survey, the investigators will assess whether parents receive the recommended anticipatory guidance topics. scale, 0-100, higher is better

Interventions

  • OTHER Parent Coach

Study Locations (2)

California

  • University of California, Los Angeles - Los Angeles

Washington

  • Seattle Children's Research Institute - Seattle

Trial Details

FieldValue
Enrollment Target 937 participants
Start Date 2019-03-05
Est. Completion 2022-07-14
Phase NA
Seattle Children's Hospital

168 total trials

What the finished NCT03797898 record still lists

NCT03797898 is an interventional study that assigns participants to a tested intervention. The registered 937 participants enrollment target is mid-sized for trials with a published cap, below the 8,885-participant average among 10 other Health Promotion trials with a reported enrollment target (89% lower).

The record links to 2 conditions, with Health Promotion appearing as the primary indexed condition, and to 1 intervention - of which Parent Coach is the first listed.

NCT03797898 reports a single indexed study location in California, Washington.

Frequently Asked Questions

What is clinical trial NCT03797898 about?

NCT03797898 is a clinical study titled "Well-Child Care Clinical Practice Redesign: A Parent Coach-Led Model of Care". Parent-focused Redesign for Encounters, Newborns to Toddlers (PARENT) is a team-based approach to care using a health educator ("Parent Coach") to provide the bulk of WCC services, address specific needs faced by families in low-income communities, and decrease reliance on the clinician as the prima...

What is the current status of trial NCT03797898?

This trial is currently completed. It is a NA study. The enrollment target is 937 participants. The study started on 2019-03-05. Estimated completion is 2022-07-14.

What conditions does trial NCT03797898 study?

This clinical trial studies the following conditions: Health Promotion, Preventive Health Services.

What interventions are being tested in trial NCT03797898?

The interventions under investigation include: Parent Coach (OTHER).

Who is sponsoring clinical trial NCT03797898?

This trial is sponsored by Seattle Children's Hospital, which has 168 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03797898 being conducted?

This trial has 2 study locations across California, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Health Promotion

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03797898's enrollment target sits among peer trials

937 4th of 10 higher than 7 of 10 other Health Promotion trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Health Promotion trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05519007 · 936 participants · NA

    Rate of Total Joint Infection 90-day After Surgery Following Irrigation With Next Science No-Rinse Solution vs SOC Alone

  • NCT03075696 · 940 participants · Phase 1

    A Dose Escalation Study of Glofitamab (RO7082859) as a Single Agent and in Combination With Obinutuzumab, Administered After a Fixed, Single Pre-treatment Dose of Obinutuzumab in Participants With Relapsed/Refractory B-cell Non-hodgkin's Lymphoma

  • NCT06855277 · 940 participants · Phase 3

    Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC

  • NCT04626635 · 933 participants · Phase 1

    A Trial to Find Out How Safe REGN7075 is and How Well it Works in Combination With Cemiplimab for Adult Participants With Advanced Cancers

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03797898, the US trial registry maintained by the National Library of Medicine. NCT03797898 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.